4D Molecular Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$28.56 | $1.59 B | -7.1 | 60 | $0 |
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.19 | $291.95 M | -3.13 | 54 | $0 |
BMEA
Biomea Fusion, Inc. |
$4.01 | $148.81 M | -1.17 | 107 | $0 |
CCCC
C4 Therapeutics, Inc. |
$3.87 | $320.64 M | -1.97 | 145 | $20.76 M |
CGEM
Cullinan Oncology, Inc. |
$12.27 | $1.29 B | -7.16 | 85 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$29.62 | $1.65 B | -11.47 | 108 | $0 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
GOSS
Gossamer Bio, Inc. |
$0.84 | $124.06 M | -0.65 | 135 | $0 |
IPSC
Century Therapeutics, Inc. |
$1.03 | $244.54 M | -1.32 | 152 | $2.24 M |
KRON
Kronos Bio, Inc. |
$0.95 | $44.62 M | -0.37 | 58 | $6.29 M |
LYRA
Lyra Therapeutics, Inc. |
$0.17 | $19.53 M | -0.27 | 88 | $1.56 M |
MLYS
Mineralys Therapeutics, Inc. |
$12.80 | $652.38 M | -6.03 | 28 | $0 |
NVCT
Nuvectis Pharma, Inc. |
$4.65 | $116.38 M | -4.5 | 13 | $0 |
PASG
Passage Bio, Inc. |
$0.65 | $73.04 M | -0.77 | 58 | $0 |
REPL
Replimune Group, Inc. |
$12.50 | $485.18 M | -2.44 | 331 | $0 |
RVMD
Revolution Medicines, Inc. |
$44.39 | $6.66 B | -10.51 | 490 | $11.58 M |
STOK
Stoke Therapeutics, Inc. |
$11.32 | $774.50 M | -6.14 | 110 | $8.78 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |